Institutional Ownership Halozyme Therapeutics, Inc. (HALO)
This table provides information about the institutional ownership of Halozyme Therapeutics, Inc. (HALO). We have compiled data on the 604 institutions that hold shares in the stock, with a total of 127 Million shares, which have been reported (via 13F filing form) to have a value of $9.62 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
480,400
shares
|
$36.5 Million
0.01% of portfolio
|
Q2 2025
Reduced 66.38%
|
|
|
Hrt Financial LP
New York, NY |
Aug 14, 2025 Q2 2025 |
467,070
shares
|
$35.5 Million
0.14% of portfolio
|
Q2 2025
Added 576.08%
|
|
|
Empowered Funds, LLC
|
Aug 11, 2025 Q2 2025 |
466,603
shares
|
$35.5 Million
0.29% of portfolio
|
Q2 2025
Added 3843.57%
|
|
|
Bi Asset Management Fondsmaeglerselskab A
Kobenhavn, G7 |
Aug 14, 2025 Q2 2025 |
444,947
shares
|
$33.8 Million
0.23% of portfolio
|
Q2 2025
Added 19.13%
|
|
|
Two Sigma Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
439,838
shares
|
$33.5 Million
0.05% of portfolio
|
Q2 2025
Reduced 31.92%
|
|
|
Boston Partners
Boston, MA |
Aug 07, 2025 Q2 2025 |
431,345
shares
|
$32.8 Million
0.03% of portfolio
|
Q2 2025
Added 4.18%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
Aug 13, 2025 Q2 2025 |
415,276
shares
|
$31.6 Million
0.55% of portfolio
|
Q2 2025
Reduced 12.47%
|
|
|
Sei Investments CO
Oaks, PA |
Aug 14, 2025 Q2 2025 |
411,378
shares
|
$31.3 Million
0.03% of portfolio
|
Q2 2025
Added 109.12%
|
|
|
Met Life Investment Management, LLC
Whippany, NJ |
Aug 13, 2025 Q2 2025 |
398,922
shares
|
$30.3 Million
0.13% of portfolio
|
Q2 2025
Added 16.05%
|
|
|
Mizuho Markets Americas LLC
|
Aug 01, 2025 Q2 2025 |
397,333
shares
|
$30.2 Million
0.51% of portfolio
|
Q2 2025
Added 6.19%
|
|
|
Marshall Wace, LLP
London, X0 |
Aug 13, 2025 Q2 2025 |
389,131
shares
|
$29.6 Million
0.02% of portfolio
|
Q2 2025
Reduced 16.06%
|
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Aug 13, 2025 Q2 2025 |
381,745
shares
|
$29 Million
0.01% of portfolio
|
Q2 2025
Reduced 8.57%
|
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
381,649
shares
|
$29 Million
0.02% of portfolio
|
Q2 2025
Reduced 8.57%
|
|
|
Retirement Systems Of Alabama
|
Aug 04, 2025 Q2 2025 |
380,379
shares
|
$28.9 Million
0.07% of portfolio
|
Q2 2025
Reduced 1.1%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
378,800
shares
|
$28.8 Million
0.02% of portfolio
|
Q2 2025
Added 1043.1%
|
|
|
Citigroup Inc
|
Aug 11, 2025 Q2 2025 |
377,507
shares
|
$28.7 Million
0.01% of portfolio
|
Q2 2025
Reduced 35.23%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
368,066
shares
|
$28 Million
0.04% of portfolio
|
Q2 2025
Added 2.37%
|
|
|
Principal Financial Group Inc
Des Moines, IA |
Aug 08, 2025 Q2 2025 |
349,947
shares
|
$26.6 Million
0.01% of portfolio
|
Q2 2025
Reduced 7.91%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Aug 13, 2025 Q2 2025 |
338,609
shares
|
$25.8 Million
0.02% of portfolio
|
Q2 2025
Added 182.15%
|
|
|
Legal & General Group PLC
London, X0 |
Aug 12, 2025 Q2 2025 |
337,567
shares
|
$25.7 Million
0.0% of portfolio
|
Q2 2025
Added 7.47%
|
|
|
Cerity Partners LLC
New York, NY |
Aug 13, 2025 Q2 2025 |
325,894
shares
|
$24.8 Million
0.03% of portfolio
|
Q2 2025
Added 12.03%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Aug 14, 2025 Q2 2025 |
311,398
shares
|
$23.7 Million
0.0% of portfolio
|
Q2 2025
Added 292.15%
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Aug 12, 2025 Q2 2025 |
310,830
shares
|
$23.6 Million
0.24% of portfolio
|
Q2 2025
Reduced 9.42%
|
|
|
Mesirow Institutional Investment Management, Inc.
Chicago, IL |
Feb 13, 2025 Q4 2024 |
302,148
shares
|
$23 Million
1.14% of portfolio
|
Q4 2024
Added 37.65%
|
|
|
Barclays PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
295,535
shares
|
$22.5 Million
0.0% of portfolio
|
Q2 2025
Added 18.25%
|